Active substance
Glycerol
- SFDA 12
- Health Canada 1
- US price lines 3
- NHS prices 3
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Dawaa Health Glycerin | 700 mg | Suppository · Rectal use | 12 Blister | SAR 59.00 | Generic · OTC | Al Dawaa Medical Services Co Ltd | Valid |
| Dawaa Health Glycerin | 1400 mg | Suppository · Rectal use | 12 Blister | SAR 66.05 | Generic · OTC | Al Dawaa Medical Services Co Ltd | Valid |
| Dawaa Health Glycerin | 2800 mg | Suppository · Rectal use | 12 Blister | SAR 90.10 | Generic · OTC | Al Dawaa Medical Services Co Ltd | Valid |
| Glycelax | 700 mg | Suppository · Rectal use | 12 Blister | SAR 62.10 | Generic · OTC | Unicare Pharma | Valid |
| Glycelax | 1400 mg | Suppository · Rectal use | 12 Blister | SAR 69.55 | Generic · OTC | Unicare Pharma | Valid |
| Glycelax | 2800 mg | Suppository · Rectal use | 12 Blister | SAR 94.85 | Generic · OTC | Unicare Pharma | Valid |
| Jocerine | 1365 mg | Suppository · Rectal use | 21 Blister | SAR 25.55 | Generic · OTC | JORDAN RIVER PHARMACEUTICAL INDUSTRIES | Valid |
| Jocerine | 2.5 g | Suppository · Rectal use | 21 Blister | SAR 29.20 | Generic · OTC | JORDAN RIVER PHARMACEUTICAL INDUSTRIES | Valid |
| LAXOLYNE SUPP FOR CHILDREN | 900 mg | Suppository · Rectal use | 10 Blister | SAR 6.20 | Generic · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
| LAXOLYNE SUPPOSITORIES | 1800 mg | Suppository · Rectal use | 10 Blister | SAR 6.20 | Generic · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
| GLICEROLO SUPP 1500MG CHILDREN | 1500 mg | Suppository · Rectal use | 18 Box | SAR 4.65 | NCE · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
| GLYCERINE INFANTILE SUPPOSITORY | 700 mg | Suppository · Rectal use | 12 Blister | SAR 3.05 | Generic · Prescription | THE NILE COMPANY FOR PHARMACEUTICALS AND CHEMICAL IND. | Suspended · Not Marketed |
Indications — CHI Daman Drug Formulary
ANAL FISSURE
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| NEGATIVE SKIN TEST CONTROL - GLYCERIN | 02426773 | 50 % / V/V | LIQUID · PERCUTANEOUS | JUBILANT HOLLISTERSTIER LLC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CHILD GLYCERIN 1.2 GM SUPP | $0.12192 | per EA | 23 Sep 2026 |
| US NADAC | GLYCERIN 2 GM SUPPOSITORY | $0.21712 | per EA | 21 Jan 2026 |
| US NADAC | GLYCERIN 2 GM SUPPOSITORY | $0.10312 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Glycerol 1g suppositories | £3.48 | 12 suppository | 1 Oct 2026 |
| NHS Drug Tariff | Glycerol 2g suppositories | £3.49 | 12 suppository | 1 Oct 2026 |
| NHS Drug Tariff | Glycerol 4g suppositories | £2.07 | 12 suppository | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 13.6. Dermatological medicines > Moisturizers · core
Atopic eczema
Local > Topical > Cream: 15 to 20%
Combinations containing Glycerol
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.